Skip to main content

About

  • Our Organization
  • WHS Academic Alliance
  • Network

Events

  • Annual Summit
  • Regional Meetings
  • Other Events

Media

  • News
  • Press
  • Media Library
  • Newsletter
  • Imprint
  • Privacy Policy
2025
  1. Home
  2. —
  3. Program
  4. —
  5. PD 10 – Global Health Financing at the Tipping Point
PANEL DISCUSSIONPD 10IN-PERSON ONLY

Global Health Financing at the Tipping Point

Crisis or Catalyst for Change?

Date

Monday, 13th October

Time

09:00-10:30 CEST

07:00-08:30 UTC

Room

Pavillon

Co-Host(s)

Federal Ministry of Health of Germany (BMG)

Share this Page

About the session

Global health (GH) is at a crossroads as it faces an unprecedented financial crisis. Existing resource constraints have been exacerbated by budget cuts, reduced multilateral support, and the U.S. withdrawal from GH institutions and financing. The GH financial crisis threatens the ability of GH institutions to deliver on their key mandates and missions. At the same time, this crisis can present the long-needed stimulus for rethinking the fragmented GH financing ecosystem and initiating transformative processes to effectively prioritize GH investments in a changing world. Amid the unprecedented challenges and devastating impacts of the disruption in GH financing, it might serve as a catalyst for systemic reforms to build a more resilient, efficient, and equitable GH financing system.

To navigate funding shortfalls, international health institutions are already implementing or have initiated reform and restructuring processes to contain costs and (re-)define priorities. Various reform proposals are being considered ranging from (re-)focusing on core mandates and functions, streamlining mandates, or increasing efficiencies to more profound changes such as merging institutions or even sunsetting certain areas.

The session will explore how institutions are adapting to shrinking financial spaces and aims to foster dialogue around sustainable strategies to navigate the crisis. How are GH institutions reacting? What role does “innovative financing” play? Is there a “power shift” in GH financing? Does the shift in financing present an opportunity for Low- and Middle-Income Countries (LMICs) to build self-sustaining, locally led systems? In this session, we will discuss reform pathways to a new GH financing ecosystem.
See all Sessions

Chair(s) / Moderator(s)

undefined undefined

Björn Kümmel

Federal Ministry of Health (BMG)
Head of Unit Global Health
Germany

Open

Speakers

undefined undefined

Ruth Lawson

Foreign, Commonwealth & Development Office (FCDO)
Deputy Permanent Representative for Global Health and UK Representative to the Global Health Boards | Friends of Lusaka Agenda
United Kingdom

Open
undefined undefined

Sania Nishtar

Gavi, the Vaccine Alliance
CEO
Switzerland

Open
undefined undefined

Kieran Daly

Gates Foundation
Global Health Agencies and Funds | Director
United States of America

Open
undefined undefined

Peter Sands

The Global Fund to Fight AIDS, Tuberculosis and Malaria
Executive Director
Switzerland

Open
undefined undefined

Barbara Schedler Fischer

Federal Office of Public Health (FOPH)
Ambassador for Global Health
Switzerland

Open
undefined undefined

Priya Basu

The Pandemic Fund
Executive Head
United States of America

Open
undefined undefined

Kalipso Chalkidou

World Health Organization (WHO)
Department of Performance, Financing and Delivery (PFD) | Director
Switzerland

Open
undefined undefined

Ngashi Ngongo

Africa Centres for Disease Control and Prevention (Africa CDC)
Chief of Staff and Head of the Executive Office

Open
See all Sessions

Share this Page